The Company is supported by a Medical Advisory Board (MAB) with extensive experience in the practice of transfusion medicine. All members of our MAB are clinicians with expertise in all facets of blood banking and a thorough familiarity with the risks of bacterial contamination of blood components. As active consultants to the Company, they offer Verax guidance in the areas of product design and clinical trial planning.
James P. AuBuchon, M.D, Dartmouth-Hitchcock Medical Center
Dr. AuBuchon is Chair of Pathology and Professor of Medicine and the Medical Director of Blood Bank and Transfusion Services at the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.
Mark E. Brecher, M.D., University of North Carolina Hospitals
Dr. Brecher is the Director of the Transfusion Medicine Service and the Stem Cell Laboratory at the University of North Carolina Hospitals.
Ira A. Shulman, M.D., University of Southern California
Dr. Shulman is a Professor and Vice Chair of Pathology, and Director of Transfusion Medicine at the Keck School of Medicine of the University of Southern California. He is also the Director of Laboratories and Pathology at the Los Angeles County+USC Medical Center.
Leslie E. Silberstein, M.D., Harvard Medical School
Dr. Silberstein is a Professor in Pathology, Harvard Medical School, and Director of the Joint Program in Transfusion Medicine for Childrens Hospital Boston, Brigham and Womens Hospital and the Dana Farber Cancer Institute.
Roslyn Yomtovian, M.D., Case Western Reserve University
Dr. Yomtovian is a Professor in the Department of Pathology at the Case Western Reserve University School of Medicine, Cleveland, Ohio.
